Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Tracking error happens when a fund deviates from its index due to replication method, fees, or liquidity. Grasp the causes to improve tracking.
22,885 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A real estate rally this year is being led by data-center REITs powering AI, pushing the sector to outsized gains eve...
NVIDIA is a marquee AI play, but there are smarter, more diversified ways to capture the AI infrastructure boom. This...
Investors are watching for Fed moves as a key driver of market performance. This year could bring a handful of rate c...
When crude climbs and stock futures fall, Bitcoin often faces a test it can’t ignore. This guide breaks down why the ...
Long-term compound growth in tech requires durable moats and disciplined capital allocation. Here are two powerhouse ...
Volatility is rising and daily balance checks may hurt more than help. This piece explains why experts stop checking ...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
May consumer sentiment slips again as high gas prices squeeze household budgets. The Michigan reading signals a broad...
As the AI-powered mood shifts, Micron faces pressure from memory-market concerns. This article breaks down what the m...
Stocks rise as investors seek durable earnings power in blue-chip names. history says this unstoppable Dow juggernaut...
As provisional income passes the 34K mark, a sizable share of Social Security benefits can become taxable for single ...